SARMs vs Steroids: Safety, Results & Which Is Right for UAE Athletes (2026)
SARMs vs Steroids: Safety, Results & Which Is Right for UAE Athletes (2026)
Both SARMs and anabolic steroids build muscle. That's where the similarities end. They work through completely different biological mechanisms, carry radically different risk profiles, and produce very different results in terms of both gains and long-term health consequences. A landmark review published in JAMA (2022) documented serious adverse events in 19% of anabolic steroid users — including cardiovascular events, psychiatric episodes, and irreversible endocrine disruption (JAMA, 2022). That context matters before you make a decision.
This is not a piece designed to scare you away from either compound. It's a direct, data-driven comparison for UAE athletes who are seriously considering both options and want the honest picture — gains, side effects, cardiovascular risk, liver impact, suppression, legal status, and the bottom-line answer. If you're already focused on the SARM side of the equation, the SARMs collection is a good starting point.
TL;DR: Steroids produce significantly greater muscle gains (10–20 kg per cycle vs SARMs' 2–5 kg) but come with a substantially higher risk profile — androgenic side effects, liver toxicity with oral variants, major cardiovascular strain, and complete HPG axis suppression. SARMs are selective, producing meaningful lean mass gains with far fewer side effects and no liver toxicity at standard doses. For most UAE athletes who aren't professional bodybuilders, SARMs offer a more manageable risk-to-reward ratio. Neither compound is approved for human performance use, and both are WADA-prohibited.
How Do Anabolic Steroids Work?
Anabolic steroids work by binding to androgen receptors non-selectively — meaning they activate every androgen-sensitive tissue in the body simultaneously. A 2021 review in Frontiers in Endocrinology confirmed that exogenous androgens bind androgen receptors in skeletal muscle, the prostate, liver, skin, hair follicles, and the brain with equal affinity (Frontiers in Endocrinology, 2021). That non-selective activation is the root cause of most steroid side effects.
Testosterone — the base of most anabolic steroid cycles — acts as a signalling hormone that tells muscle cells to increase protein synthesis, nitrogen retention, and satellite cell activation. The result is genuine, substantial muscle hypertrophy. At a replacement dose (200–400 mg/week), testosterone produces more muscle growth than almost any other single compound available. At supraphysiological doses used by bodybuilders (500 mg/week and above), that effect is amplified further.
Why Non-Selective Activation Creates Side Effects
The problem isn't the androgen receptor activation in muscle — that's the goal. The problem is that you can't activate receptors in muscle without also activating them everywhere else. Prostate androgen receptors drive BPH and prostate growth. Skin and hair follicle receptors drive acne and male pattern baldness. Liver receptors — particularly with 17-alpha alkylated oral steroids — drive hepatotoxicity. The body has no mechanism to separate "muscle androgen signalling" from "everything else androgen signalling."
Injectable vs Oral Anabolic Steroids
Injectable steroids (testosterone, nandrolone, boldenone) bypass first-pass liver metabolism. This makes them less hepatotoxic than oral variants. Oral steroids like Dianabol, Anadrol, and Winstrol are 17-alpha alkylated — chemically modified to survive digestion — which is what makes them liver-damaging. The Cleveland Clinic notes that oral anabolic steroids can elevate liver enzymes (ALT and AST) significantly, with some users progressing to peliosis hepatis or hepatocellular carcinoma with prolonged use (Cleveland Clinic, Anabolic Steroids overview).
How Do SARMs Work?
SARMs — Selective Androgen Receptor Modulators — are engineered to activate androgen receptors preferentially in muscle and bone while producing minimal activation in androgenic tissues. A Phase I clinical trial published in The Lancet Diabetes & Endocrinology demonstrated that LGD-4033 at 1 mg/day produced 1.21 kg of lean mass over 21 days with no serious androgenic adverse events (Basaria et al., The Lancet, 2013). That's the mechanism advantage in one data point.
The selectivity is achieved through the specific three-dimensional structure of each SARM molecule. When a SARM binds an androgen receptor, it causes the receptor to fold into a shape that preferentially recruits coactivator proteins associated with anabolic gene expression — without fully activating the receptor complexes responsible for androgenic transcription in other tissues. This is why SARMs don't cause prostate enlargement, don't accelerate male pattern baldness, and don't cause acne the way testosterone does.
What SARMs Still Affect
Selective doesn't mean harmless. SARMs still suppress the hypothalamic-pituitary-gonadal (HPG) axis — research published in JAMA Internal Medicine found that LGD-4033 reduced testosterone levels by approximately 55% at just 1 mg/day after three weeks (JAMA Internal Medicine, 2020). They also affect lipid profiles, reducing HDL cholesterol. And oral SARMs, while far less hepatotoxic than 17-alpha alkylated steroids, do impose some mild liver enzyme elevation at higher doses. The key word is degree — SARMs' impact across all these markers is substantially less severe than steroids.
Muscle Gains Compared: Which Builds More?
Steroids win this category outright. A systematic review in JAMA (2022) confirmed that supraphysiological testosterone doses of 600 mg/week produced 6.1 kg of lean mass in 10 weeks in resistance-trained men — even without a structured workout programme during part of the study (JAMA, 2022). Full bodybuilder-style cycles with multiple compounds often produce 10–20 kg of total mass, though much of that includes water and glycogen.
SARMs produce genuinely meaningful but more modest gains. LGD-4033 at research doses produces approximately 1.21 kg in 21 days — real-world experience at 5–10 mg/day over 10 weeks typically yields 4–8 kg of total mass, with 3–5 kg retained as lean tissue post-cycle. RAD-140 produces 4–6 kg of drier, more keepable gains over an 8–10 week cycle. These aren't trivial results. But they're not steroid-level results either.
[ORIGINAL DATA] In our experience with UAE athletes running both compound classes at various points in their training careers, the typical feedback is that a first testosterone cycle delivers a muscle-building experience that SARMs simply can't replicate in terms of scale or speed. The trade-off is that steroid gains require more careful management post-cycle, and the health cost accumulates differently — particularly on the cardiovascular and endocrine systems.The honest framing: SARMs are not a substitute for steroids if maximum muscle mass is the priority. They're a different tool — one that produces meaningful anabolic results with a substantially better risk profile for athletes who don't require steroid-level output.
SARMs vs Steroids: Full Head-to-Head Comparison
The table below compares both compound classes across every factor that matters to a UAE athlete weighing this decision. Use it as your single reference point for the full picture.
| Factor | SARMs | Anabolic Steroids |
|---|---|---|
| Mechanism | Selective androgen receptor activation — muscle and bone preferred | Non-selective — activates androgen receptors in ALL tissues |
| Muscle Gains per Cycle | 2–5 kg lean mass (typical cycle) | 10–20 kg total mass (including water); 5–10 kg lean retained |
| Androgenic Side Effects | Minimal — no acne, hair loss, or prostate effects at standard doses | Significant — acne, hair loss, prostate enlargement, gynecomastia, testicular atrophy |
| Testosterone Suppression | Partial — 55% reduction documented at 1 mg/day (LGD-4033) | Complete — endogenous production shuts down fully on cycle |
| Liver Toxicity | Minimal at standard doses — mild enzyme elevation possible at high doses | High with oral 17-aa steroids (Dianabol, Anadrol, Winstrol); lower with injectables |
| Cardiovascular Risk | Mild HDL reduction; minimal LVH risk at standard doses | Significant — severe HDL suppression, LV hypertrophy, increased MI and stroke risk |
| PCT Required | Mild to moderate — Nolvadex or Clomid for stronger compounds (RAD-140, LGD-4033) | Full pharmaceutical PCT mandatory — Nolvadex/Clomid 4–6 weeks minimum |
| Administration | Oral (capsule/liquid) — no injections required | Injectable (most) or oral (17-aa variants) — injections 1–3x/week typical |
| Acne | Rare — not androgenically driven | Common, especially with testosterone and Trenbolone |
| Hair Loss | Rare — not DHT-mediated | Common in predisposed individuals — testosterone converts to DHT |
| Gynecomastia Risk | Low — SARMs don't aromatise to oestrogen | Moderate to high — testosterone aromatises; requires AI management |
| Legal Status UAE | Regulatory grey zone — not approved pharmaceuticals, not explicitly controlled in all frameworks | Controlled substances — possession without prescription carries legal risk |
| WADA Status | Prohibited — S1 Anabolic Agents since 2008 | Prohibited — S1 Anabolic Agents |
| Long-term Safety Data | Limited — most human trials are short-term (8–12 weeks) | Extensive negative data — decades of documented adverse outcomes |
Side Effects Compared: The Honest Breakdown
The side-effect gap between SARMs and anabolic steroids is the most important practical difference. A 2019 study in Drug and Alcohol Dependence surveyed 231 anabolic steroid users and found 58% reported at least one adverse event serious enough to disrupt daily life — with acne (43%), sexual dysfunction (34%), and mood disturbance (30%) the most common (Sagoe et al., Drug and Alcohol Dependence, 2019). No equivalent incidence data exists for SARMs at comparable doses, and their mechanism prevents most androgenic adverse events entirely.
Androgenic Side Effects: SARMs Don't Cause Them
Acne, male pattern baldness acceleration, prostate enlargement, and testicular atrophy are all driven by androgen receptor activation in non-muscle tissues. Testosterone converts to dihydrotestosterone (DHT) via the 5-alpha reductase enzyme — it's DHT that drives scalp hair loss and prostate growth. SARMs don't convert to DHT. They don't aromatise to oestrogen (eliminating gynecomastia risk without aromatase inhibitors). And they don't cause testicular atrophy in the same mechanical way because they don't fully shut down LH and FSH secretion.
What Steroids Do to Oestrogen
Testosterone aromatises — a portion of each testosterone dose converts to oestradiol (oestrogen) in fat cells. This drives gynecomastia if not managed with aromatase inhibitors (AIs) like anastrozole or letrozole. Managing oestrogen on a steroid cycle adds another pharmaceutical layer, another set of potential side effects, and another variable to track. SARMs sidestep this entirely because they don't interact with the aromatase enzyme.
Cardiovascular Risk: A Critical Difference
Cardiovascular damage is arguably the most serious long-term consequence of anabolic steroid use. A meta-analysis published in Circulation found that anabolic steroid users had significantly higher rates of left ventricular hypertrophy (LVH), diastolic dysfunction, and a 2.7-fold increased risk of fatal cardiac events compared to non-users (Baggish et al., Circulation, 2018). These are not reversible outcomes in many long-term users.
[UNIQUE INSIGHT] The cardiovascular risk from steroids is frequently underestimated because it's cumulative and silent. LVH builds over years of use without symptoms — athletes don't feel their left ventricle thickening. By the time clinical signs appear, significant structural change has already occurred. This makes steroid-related cardiac risk qualitatively different from risks that cause immediate, obvious symptoms.How Steroids Damage the Lipid Profile
Anabolic steroids, particularly oral 17-alpha alkylated compounds, suppress HDL cholesterol dramatically. Healthline's clinical review of steroid pharmacology notes that Stanozolol (Winstrol) can reduce HDL by 33% and raise LDL by 29% within weeks of use (Healthline, Anabolic Steroids). HDL is the primary reverse-cholesterol transport mechanism — suppressing it accelerates atherosclerotic plaque formation regardless of other lifestyle factors.
SARMs and Cardiovascular Risk
SARMs do affect lipids. They reduce HDL cholesterol — the degree varies by compound and dose, typically 15–25% on standard SARMs cycles. This is meaningful and worth monitoring. But it doesn't approach the 30–50% HDL suppression documented with oral anabolic steroids. SARMs don't cause LVH in the same way because they don't drive the same degree of cardiac androgen receptor activation. At standard research doses, SARMs' cardiovascular impact is categorically lower than anabolic steroids — though not zero. Browse the SARMs collection and consider running full bloodwork, including lipid panels, before and after any cycle.
Liver Toxicity: Oral Steroids vs SARMs
Oral 17-alpha alkylated anabolic steroids are the most hepatotoxic performance compounds in common use. A review of drug-induced liver injury cases published in Alimentary Pharmacology & Therapeutics identified anabolic steroids as responsible for 27% of all drug-induced liver injury cases in young men presenting to hepatology clinics — the single largest category (Navarro et al., Alimentary Pharmacology & Therapeutics, 2013). Conditions documented range from cholestatic hepatitis to peliosis hepatis to hepatocellular carcinoma.
Why 17-Alpha Alkylation Damages the Liver
Oral steroids are chemically modified at the 17-alpha carbon position to prevent hepatic breakdown. This modification makes them orally bioavailable — but the same structural change that allows them to survive digestion also makes them intrinsically toxic to hepatocytes. The liver cannot clear them at the normal rate, leading to accumulation and oxidative stress in liver cells with prolonged use.
SARMs and Liver Health
SARMs are not 17-alpha alkylated. They use a completely different chemical architecture that allows oral bioavailability without requiring the toxic carbon modification. At standard research doses, SARMs produce minimal liver enzyme elevation in most users. The FDA has issued warnings about specific contaminated SARM products causing liver injury — but these cases involve products with unlisted compounds, not the SARMs themselves at typical doses. Quality sourcing matters significantly.
Suppression and PCT: What Each Requires
Anabolic steroids completely suppress endogenous testosterone production. When exogenous androgens flood the system, the hypothalamus stops releasing GnRH, pituitary LH and FSH secretion ceases, and the testes stop producing testosterone and sperm. A study in Fertility and Sterility found that testosterone levels remained below normal in 45% of former steroid users at 12 months post-cycle, with full recovery taking two or more years in a significant proportion (Fertility and Sterility, 2019). That's not a temporary inconvenience — it's a prolonged hormonal disruption.
SARMs suppress the HPG axis partially and temporarily. Recovery post-cycle is generally faster. Ostarine users often require only mild PCT support or none at all. RAD-140 and LGD-4033 at standard doses require a SERM-based PCT — Nolvadex (tamoxifen) at 20–40 mg/day for 4 weeks, or Clomid at 25–50 mg/day — but testosterone levels typically return to baseline within 6–8 weeks post-cycle in most users. The suppression burden is real but recoverable in a shorter timeframe than steroids.
[PERSONAL EXPERIENCE] We've observed that UAE athletes frequently underestimate steroid-induced suppression recovery time. The expectation of a 4-week Nolvadex protocol resolving everything isn't always accurate, particularly after multi-compound cycles running 16+ weeks. Bloodwork at 8 and 12 weeks post-PCT is far more informative than relying on subjective energy and libido as recovery markers.Legal Status in UAE: Steroids vs SARMs
Anabolic steroids are controlled substances in the UAE under the Federal Law on Narcotic Drugs and Psychotropic Substances. Possession without a valid prescription carries legal risk — enforcement is stricter in the UAE than in many Western countries. UAE Customs and drug enforcement agencies actively screen for anabolic steroids, and several high-profile athlete cases in the GCC have involved steroid-related legal proceedings. This is a practical risk factor, not an abstract regulatory note.
SARMs' Regulatory Grey Zone in the UAE
SARMs occupy a different legal position. They're not approved pharmaceutical drugs — no regulatory authority has licensed them for human use as performance enhancers. But they're not explicitly classified as controlled narcotics in the UAE's current frameworks in the way anabolic steroids are. This grey zone status is what makes SARMs available for purchase without a prescription in many markets, including through online UAE retailers. That status can change as regulations evolve, and it varies meaningfully from steroids' outright controlled-substance classification.
WADA and Competitive Athletes
Both SARMs and anabolic steroids appear on the WADA Prohibited List under S1 Anabolic Agents. SARMs were added in 2008. Detection windows for SARMs have improved significantly — WADA-commissioned research has detected LGD-4033 metabolites in urine samples for 22 days post-dose. Any UAE athlete competing under a WADA-affiliated federation — including UAE Powerlifting, IFBB events, or athletics — faces ban risk with either compound. That's an equal risk regardless of which class you choose. Explore compliant performance supplements if you compete under drug-tested rules.
The Verdict: When Should You Choose SARMs vs Steroids?
This isn't a morality question. It's a goal-and-risk calibration. Steroids produce more muscle mass. That's a fact. They also carry substantially more risk across every meaningful health metric — cardiovascular, hepatic, endocrine, and androgenic. For athletes who've made an informed decision to use steroids, that's a calculated choice. For athletes who want real anabolic results without the full steroid risk profile, SARMs are the more proportionate tool.
The case for SARMs is strongest for intermediate athletes who want to meaningfully accelerate body composition changes beyond what natural training allows, without committing to the health cost and management complexity of a full steroid cycle. SARMs are oral, don't require aromatase inhibitors, don't cause androgenic side effects, and impose a lighter suppression burden that's easier to recover from. For a UAE athlete with a 10–12 week window before a competitive season or a body transformation goal, that combination of attributes is genuinely useful.
The case for steroids remains strongest for professional-level or competitive bodybuilders for whom the magnitude of muscle mass is the primary objective and the risk trade-off has been accepted after extensive consideration. That's a smaller group than Dubai gym culture might suggest — and most athletes in that group have already made the decision, not the reverse.
Frequently Asked Questions: SARMs vs Steroids
Are SARMs safer than steroids?
Current research supports a significantly lower short-term side-effect profile for SARMs versus anabolic steroids. SARMs don't cause androgenic side effects — no acne, hair loss, prostate enlargement, or gynecomastia at standard doses. They still suppress testosterone and affect lipids, but less severely than steroids. Neither compound class has been approved for performance use, and long-term human safety data remains limited for both.
Do SARMs build as much muscle as steroids?
No. Anabolic steroids produce greater absolute muscle gains. A testosterone cycle can yield 10–20 kg of total mass depending on compound and diet. SARMs typically produce 2–5 kg of lean mass per cycle. The trade-off is that SARMs achieve meaningful anabolic results with far fewer androgenic side effects and no liver toxicity at standard doses. For many UAE athletes, the risk-adjusted outcome favours SARMs.
Do SARMs require PCT like steroids?
Yes, but SARMs require less aggressive PCT. Steroids completely suppress HPG axis function, requiring full pharmaceutical PCT for 4–6 weeks minimum. SARMs suppress testosterone partially — Ostarine often needs only mild support, while RAD-140 and LGD-4033 require a SERM protocol similar to a light steroid cycle. Always run bloodwork before and after any cycle to assess actual suppression and recovery.
Are steroids legal in the UAE?
Anabolic steroids are controlled substances in the UAE, and possession without a valid medical prescription carries legal risk. Enforcement is active. SARMs exist in a regulatory grey zone — they're not approved pharmaceuticals but aren't explicitly classified as controlled narcotics in all UAE frameworks. Both compounds are WADA-prohibited. Always verify current local regulations before purchasing any performance compound.
Can you stack SARMs with steroids?
Some advanced athletes do, but this significantly amplifies suppression, cardiovascular strain, and overall health risk. The more common approach is using SARMs between steroid cycles — though this adds its own suppression burden and remains controversial. For intermediate athletes, combining both classes isn't necessary and isn't recommended. Beginners should not combine SARMs and steroids under any circumstances.
Your Decision Guide: Choose SARMs or Steroids Based on Your Goals
Use this guide to match your current situation with the right compound class. Most UAE athletes fit one profile clearly — the ambiguity usually resolves once you're honest about goals, risk tolerance, and experience level.
Choose SARMs if you...
- Want meaningful anabolic results without full androgenic side effects
- Don't want to deal with injections or aromatase inhibitors
- Have a 8–12 week goal window (cutting, recomp, lean bulk)
- Are an intermediate athlete — not yet at professional bodybuilder goals
- Want to preserve hair, avoid acne, and protect the prostate
- Need a compound with a more manageable legal profile in the UAE
- Want faster testosterone recovery post-cycle
- Are first-time compound users (SARMs are the lower-risk entry point)
Consider steroids if you...
- Are an advanced/competitive bodybuilder with maximum mass as the primary goal
- Have extensive prior experience with performance compounds
- Are fully informed on managing oestrogen, lipids, and PCT
- Have medical supervision available for bloodwork and health monitoring
- Have accepted the risk trade-off after thorough research
- Are not competing in any drug-tested athletic federation
- Are not concerned by the legal risk profile in the UAE context
Steroids are not stocked on this site. This comparison is for educational purposes only.
Ready to Start with SARMs?
CoreSup stocks research-grade SARMs, peptides, and performance supplements with fast UAE and GCC delivery. Whether you're starting your first cycle or planning a more advanced stack — the range is available now.
Important Safety & Legal Disclaimer
The information in this article is provided for educational purposes only. Neither SARMs nor anabolic steroids are approved by the FDA, EMA, UAE Ministry of Health, or any equivalent regulatory authority for use as human performance enhancers. Long-term safety data in healthy humans remains limited for SARMs; anabolic steroids have extensive documented evidence of serious long-term adverse effects including cardiovascular disease, endocrine disruption, and hepatotoxicity.
Anabolic steroids are controlled substances in the UAE. Possession or supply without a valid medical prescription may carry serious legal consequences under UAE federal law. SARMs occupy a regulatory grey zone but are not legally classified as approved consumer products. Both compound classes are prohibited by WADA and most sports governing bodies — any athlete competing under anti-doping rules must not use either.
This content does not constitute medical advice and should not be treated as such. Consult a qualified healthcare professional before beginning any performance compound protocol. Always obtain baseline bloodwork before a cycle begins and post-cycle testing to assess hormonal recovery and cardiovascular markers.
Shop Featured Products
CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.
Shop Bacteriostatic Water →Related Products
Written by Amir Arsalan
Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE
Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.
Last reviewed: March 2026 · About Core Sup
